MedTrace Logo

Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

NCT02089464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2020-09-01

Study results available
· View outcomes & findings →

Summary

A pivotal, prospective, multi-center, randomized, controlled, double-blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.

Conditions

Interventions

DEVICE

NBS-guided rTMS

DEVICE

Sham rTMS

PROCEDURE

Task oriented rehabilitation

Sponsors & Collaborators

  • Nexstim Ltd

    lead INDUSTRY

Principal Investigators

  • Richard L Harvey, MD · Shirley Ryan AbilityLab

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02089464 on ClinicalTrials.gov